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Scientiﬁc Article
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Abstract
Purpose: Atelectasis (AT), or collapsed lung, is frequently associated with central lung tumors. We
investigated the variation of atelectasis volumes during radiation therapy and analyzed the effect of
AT volume changes on the reproducibility of the primary tumor (PT) position.
Methods and materials: Twelve patients with lung cancer who had AT and 10 patients without
AT underwent repeated 4-dimensional fan beam computed tomography (CT) scans during
radiation therapy per protocols that were approved by the institutional review board.
Interfraction volume changes of AT and PT were correlated with PT displacements relative to
bony anatomy using both a bounding box (BB) method and change in center of mass (COM).
Linear regression modeling was used to determine whether PT and AT volume changes were
independently associated with PT displacement. PT displacement was compared between patients
with and without AT.
Results: The mean initial AT volume on the planning CT was 189 cm3 (37-513 cm3), and
the mean PT volume was 93 cm3 (12-176 cm3). During radiation therapy, AT and PT
volumes decreased on average 136.7 cm3 (20-369 cm3) for AT and 40 cm3 (7 to 131 cm3) for
PT. Eighty-three percent of patients with AT had at least one unidirectional PT shift that was
greater than 0.5 cm outside of the initial BB during treatment. In patients with AT, the
maximum PT COM shift was 0.5 cm in all patients and >1 cm in 58% of patients (0.5-2.4
cm). Changes in PT and AT volumes were independently associated with PT displacement
(P < .01), and the correlation was smaller with COM (R2 Z 0.58) compared with the BB
method (R2 Z 0.80). The median root mean squared PT displacement with the BB method
was signiﬁcantly less for patients without AT (0.45 cm) compared with those with AT
(0.8cm, P Z .002).
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Conclusions: Changes in AT and PT volumes during radiation treatment were signiﬁcantly
associated with PT displacements that often exceeded standard setup margins. Repeated
3-dimensional imaging is recommended in patients with AT to evaluate for PT displacements
during treatment.
ª 2017 Published by Elsevier Inc. on behalf of the American Society for Radiation Oncology.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
Introduction
Conventional radiation therapy combined with
chemotherapy remains the standard of care for patients
with inoperable, locally advanced nonesmall cell lung
cancer. Unfortunately, high local recurrence rates are
observed, which are associated with poor overall sur-
vival.1 Recently, improved imaging techniques2,3 and the
inclusion of respiratory motion management4-6 have
allowed for more accurate target deﬁnition, which is
expected to improve tumor control.
Routinely, treatment planning is performed prior to
therapy and adds population-based safety margins to ac-
count for systematic and random errors during daily patient
setup.6-9 Pathoanatomic conditions such as atelectasis (AT)
can occur in up to 25% of patients with locally
advanced lung cancer and may increase tumor position
variability.10-14 There is a paucity of data that explore
interfractional tumor position and shape changes that might
be associated with AT. Available data suggest that AT can
cause changes in tumor position over the course of radia-
tion therapy that is not normally taken into account with
standard setup margins.5 Therefore, repeated imaging
during therapy and adaptive replanning have been sug-
gested to adjust for density changes and tumor displace-
ments that are associated with atelectatic changes.12
However, the frequency and magnitude of tumor position
changes in patients with AT have not been well deﬁned.
The purpose of this study was to investigate geometric
PT changes that are associated with AT. In particular, we
evaluated how changes in AT and PT volumes are related
to PT displacement during treatment. Additionally, given
the frequently observed anisotropic PT regression and
associated displacements during radiation therapy, consis-
tent anatomic landmarks (bronchi near the tumor and AT)
were selected to better estimate true tissue displacement as
a result of atelectatic change that is independent from po-
tential PT volume regression. PT displacement in patients
with and without AT was compared.
Methods and materials
Twenty-two patients with lung cancer stage Ib to IIIb
who were previously enrolled in prospective image
acquisition studies that included repeated 4-dimensional
fan beam computed tomography (CT) scans were reviewed
in accordance with an institutional review boardeapproved
protocol. The study groups consisted of 12 patients who
were treated on the basis of prior protocols and who were
found to have AT. The control group consisted of 10
consecutive patients who were enrolled in prior imaging
studies and who did not have AT. All patients were treated
with fractionated radiation therapy at standard fraction-
ation, which was combined with concurrent chemotherapy
in the majority of patients (Table 1).
Imaging acquisition
CT scans were prospectively obtained as respiration-
correlated 4-dimensional fan-beam CT scans (Brilliance
Big Bore, Philips Medical Systems) with 10 breathing
phases (0%-90%) and phase-based sorting with 3-mm
slices in the treatment position. Patients underwent a
median of 4 scans (range 2-7) during the course of
radiation therapy. A total of 97 4-dimensional fan beam
CT scans were used in this study.
Contouring
All scans were rigidly registered on the basis of the
bony anatomy of the spine to the initial planning scan
with a commercial registration and contouring package
(MIM Maestro v.6.2, Cleveland, OH). PT and AT (in the
study group only) were contoured during a single respi-
ratory phase, which remained consistent for every
repeated scan. PT and AT were contoured on the initial
planning scan with both the lung and soft tissue windows
and on all repeated scans by referencing the initial plan-
ning scan to ensure consistency. When available, diag-
nostic CT scans with contrast and positron emission
tomography (PET)-CT scans were used during contouring
to allow for differentiation between PT and AT. Bronchi
were contoured in selected patients with AT who had a
centrally located tumor near the bronchi to serve as a
consistent anatomic landmark as the PT regressed during
treatment. The mainstem bronchi were deﬁned as starting
at the carina and stopping at the division in secondary
bronchi. Secondary bronchi were deﬁned as starting at the
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secondary carina and stopping at the division of tertiary
bronchi. All PT, AT, and bronchus contours were peer
reviewed between repeated scans for accuracy and
reproducibility.
Data analysis
To evaluate the geometric changes that are associated
with AT, center of mass (COM) of the PT and bronchi
were recorded for each scan in lateral (LR), anterior-
posterior (AP), and superior-inferior (SI) directions. In
addition, the volume changes of PT and AT over time
were examined. The calculation of change in COM can be
affected by asymmetric change in the tumor (Fig. 1). The
bounding box (BB) method only measures tumor shifts,
which are outside of the initial tumor volume and likely
the most clinically relevant shifts. Therefore, we also
employed a BB method15 for comparison. We also
measured displacement of consistent anatomic landmarks
(bronchi near the tumor), which are supposedly unaf-
fected by tumor regression.
Changes in individual LR, AP, and SI COM directions
and the total 3-dimensional vector change for PT and
bronchus COMs were recorded for all scans relative to the
initial planning scan. For the BB approach, the six borders
(left, right, anterior, posterior, superior, and inferior) that
deﬁne the minimum rectilinear box that bounds the entire
structure were recorded. Changes in the BB border posi-
tions compared with the initial planning scan were
calculated in the LR, AP, and SI directions. The root
mean square (RMS) of the change over all directions was
calculated to approximate the total change in bounding
position compared with the initial planning scan. Patients
with AT were compared with patients without AT to
determine whether AT increased PT movement.
Statistics
The associations between PT and AT parameters, such
as volume reduction and PT position changes, were
analyzed using a linear regression model or
ManneWhitney U test. Signiﬁcance was assumed at
P < .05. A multivariate model with independent variables
for changes in PT and AT volumes was used to determine
an association with PT displacement using both the COM
and BB methods.
Results
Change in PT position in patients with AT
Figure 2a shows the frequency and magnitude of PT
COM shifts relative to the initial COM position during the
course of treatment with the most common shift being
between 1 and 1.5 cm. Upon examination of the
maximum shift during the course of radiation therapy for
each individual patient, the maximum shift of COM was
0.5 cm in all patients and >1 cm in 58% of patients
(range, 0.5-2.4 cm).
When using the BB method to examine the change in
PT position, we found that for 59 of 210 (28%) measured
shifts the PT was outside of the initial BB position. Most
patients (83%) had at least one unidirectional shift of the
PT >0.5 cm outside of the initial BB during the treatment
course. At any measured time point, the probability of a
shift >5 mm outside of the BB was 14% in the LR
direction, 26% in the AP direction, and 17% in the SI
direction. Figure 2B shows the RMS relative shift over all
directions, which provides an estimate of the total
movement with reference to the initial BB. An example of
change in AT that corresponds with PT displacement is
shown in Fig 1.
Change in atelectasis and PT volume over time in
patients with AT
Themean (range) initial volume ofAT from planningCT
was189 cm3 (37-513 cm3), andmeanPTvolumewas 93cm3
(12-176 cm3). Volume changes over the course of therapy
Table 1 Patient characteristics
Patient Group With
Atelectasis
Without
Atelectasis
Patients 12 10
Age (mean), y 59 63
Sex
Male 10 5
Female 2 5
Race
Caucasian 9 7
African American 3 3
AT and PT tumor size
AT volume
(mean), cm3
189 0
PT volume
(mean), cm3
93 42
Radiation Technique
3-dimensional 8 4
IMRT 4 6
Dose (range), Gy 54-70 62-70.2
Tumor Stage
T1-2 3 7
T3-4 9 3
Nodal Stage
N0-1 3 2
N2-3 9 8
Received Chemotherapy 10 10
AT, atelectasis; IMRT, intensity modulated radiation therapy; PT,
primary tumor.
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are shown in Fig 3. Both PT and AT volumes appeared to
change slowly over the course of treatment, but in rare cases
the AT volume changed abruptly. During radiation therapy,
AT and PT volumes decreased by an average of 136.7 cm3
(20-369 cm3) and 40 cm3 (-7-131 cm3), respectively. Linear
regressionwas used to estimate the change inAT and PT per
Fig. 2 Total vector shift with the center of mass (COM) method or root mean squared (RMS) shift with the bounding box (BB)
method for patients with or without atelectasis. A, The frequency of the magnitude of the shift with the COM method. B, The RMS shift
with the BB method in patients with or without atelectasis.
Fig. 1 A, Example of atelectasis volume change and primary tumor position change. The tumor at week 0 is in red, at week 5 in green,
and at atelectasis in yellow. The tumor at week 5 is transferred to the week 0 scan after fusion of week 0 and week 5 scans to the spine to
illustrate tumor movement. B, Example of atelectasis volume change and primary tumor position change. Initial atelectasis is in cyan,
initial tumor in blue, tumor at week 5 in green, and atelectasis at week 5 in purple. The scan at week 0 shows atelectasis and the initial
tumor position. The scan at week 5 shows the resolution of atelectasis and the tumor position at week 5. For color images, please access
the electronic version of this ﬁgure.
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day during treatment. Median change in AT volume was
2.56 cm3/d (0.59-13.3 cm3), and PT was 0.93 cm3/d (0.16
to 3.32 cm3).
A multivariate model with independent variables for
PT and AT volume change showed an association
with PT displacement (P < .001). The model with COM
(R2 Z 0.58) as the dependent variable showed less
correlation compared with the model that used the BB
method (R2 Z 0.80).
Change in bronchus position
Main stem bronchi could be reproducibly contoured on
repeated scans in 11 patients and secondary bronchi in 7
patients. The contoured bronchus on repeated scans was
outside the initial bronchus BB in 139 of 336 measure-
ments (41%). Maximum unidirectional shift outside the
bounding box was >1 cm in 36% of patients, and the
maximum observed unidirectional shift was 2.1 cm.
Bronchus displacements based on BB and COM were
highly correlated (R2 Z 0.90 for main stem bronchi and
R2 Z 0.96 for secondary bronchi), implying little shape
change in the bronchi during therapy. If the PT moved
outside of the BB, bronchi moved in the same direction
80% of the time. An example of bronchus and PT that
move concordantly is shown in Fig 4.
Comparison group
PT movement in patients with AT was compared with
PT movement in patients without AT to determine
whether AT increased PT movement. The initial PT was
larger for patients with AT than for those without AT
(median 80 cm3 vs 31 cm3, respectively), likely because
patients with large PT are more likely to develop AT. A
comparison of changes in COM showed a median total
vector shift for patients with AT of 0.99 cm versus 0.48
cm for patients without AT (P Z .01). The RMS tumor
movement for the BB method was signiﬁcantly less
for patients without AT compared with those with AT
Fig. 3 Volume changes in atelectasis and primary tumor during radiation therapy.
Fig. 4 Example of a patient at week 1 and week 3 during radiation therapy, which illustrates the change in bronchus position. The
primary tumor is shown in red (thin line week 2, thick line week 4) and bronchus is in green (thin line week 2, thick line week 4).
Bronchus and the primary tumor center of mass shifted medially 0.9 cm and 1.8 cm, respectively. For color images, please access the
electronic version of this ﬁgure.
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(median 0.8 cm for patients with AT vs 0.45 cm for
patients without AT; P Z .0018). A probability density
estimation was used to build histograms of the magnitude
of shifts in the AT and non-AT groups (Fig 5). The graph
shows that in patients with AT, there is a higher proba-
bility of a greater shift magnitude compared with patients
without AT.
Discussion
This is the ﬁrst study to our knowledge to quantita-
tively determine via repeated fan beam CT the change in
AT volume and related geometric PT volume during ra-
diation therapy. Previous studies have documented inter-
fraction motion of the PT and found average PT
displacements that range from 5 mm to 9 mm when
measured over the course of radiation therapy.4,5,8,16 AT,
which frequently presents in patients with locally
advanced lung cancer,11-13 has been shown to increase PT
displacements during lung radiation therapy.4,5 However,
unlike these previously mentioned studies, our study used
4-dimensional fan beam CT to quantify AT changes over
time and correlate the changes to PT displacement.
Additionally, we contoured both AT and PT on all
repeated scans throughout the radiation therapy course
and calculated the shift with both COM and BB methods.
The BB method may better represent clinically signiﬁcant
tumor shifts of targets that undergo shape and volume
changes. We found that patients with AT have increased
PT displacement compared with patients without AT and
that AT volume undergoes clinically signiﬁcant changes
during radiation therapy. Almost all patients had shifts >5
mm outside of the initial BB, with one patient experi-
encing a maximum shift of the PT outside the BB of 0.3
cm to the left, 1.1 cm anteriorly, and 0.9 cm superiorly.
All patients with AT had at least one COM shift >5 mm
during the course of treatment. Patients with AT had a
77% probability of COM shift >5 mm. These shift
magnitudes would likely result in inadequate target
coverage with typical margins if unaccounted for by
image guidance.
Determining PT movement during radiation therapy
for lung cancer is difﬁcult because of tumor regression.
All previous studies that have examined change in AT
and PT displacement to our knowledge used change in
COM of tumor relative to spine.5,12 This method assumes
that a change in tumor COM will correspond to a shift in
tumor position. However, this method is less accurate in
the common situation of lung tumor volume and shape
change during treatment because the tumor displacement
is not rigid. Therefore, to improve accuracy, we also used
the BB method and created a BB around the initial tumor.
On subsequent scans, the amount the PT outside the initial
BB was identiﬁed as a simple method to account for
shape and volume changes.
We also evaluated COM change for comparison and
found examples in which the COM method either over-
estimated or underestimated PT displacement. Both the
COM and BB methods found that PT and AT volume
changes were independently associated with PT
displacement. However, multivariate modeling (including
volume change for both PT and AT) found that the cor-
relation of PT displacement was lower with COM
compared with the BB method, which implies that the BB
method may be a more accurate means to assess PT
motion.
An example of an asymmetric response by a tumor that
resulted in a change in COM and overestimation of tumor
motion is shown in Fig 1B (patient 2). The tumor
responded asymmetrically and moved toward the medi-
astinum. Qualitatively, the tumor appears to be mostly
encompassed within the initial primary tumor and moves
slightly superiorly. When we assessed this movement
with the BB method, we found a 3-mm shift outside the
initial BB in the superior direction, which correlates
qualitatively with the image. However, when the COM
method assessed the change, it showed a 1.5-cm shift in
the superior direction, which is qualitatively incorrect.
Conversely, COM can also underestimate clinically
relevant tumor shifts. Figure 1A shows an obviously
clinically signiﬁcant shift of tumor volume in the anterior
direction. Using the BB method to assess the shift, we see
that the tumor has moved outside the initial BB anteriorly
by 1.1 cm. We ﬁnd that the COM method underestimated
the anterior shift (0.5 cm). Additionally, tumor regression
during treatment will likely bias the COM method to
underestimate the PT shift. Thus, the BB method may be
a superior method to quantify clinically relevant PT shifts.
The PT often regresses during therapy, and it can be
difﬁcult to determine whether all lung sections that were
initially affected by the tumor remain in the radiation
ﬁeld. This becomes especially important for patients with
Fig. 5 Probability density that is related to shift magnitude
for patients with atelectasis compared to patients without
atelectasis.
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AT because they are likely to experience large shifts as
the AT resolves during therapy, but the primary tumor
may experience signiﬁcant regression. In these cases, the
bronchus near the tumor may serve as a good surrogate
during patient setup if the PT is difﬁcult to identify and
decouple the effects of anatomical shift and regression.
Figure 4 shows a scan from a patient with a subcarinal
mass in which the bronchus and PT move in the same
direction. On the cone beam CT scan, bronchi may be
easier to visualize that the actual PT. However, further
study is needed to determine whether bronchi can be a
useful surrogate for tumor motion. Although there was
80% concordance of movement between bronchi and
the tumor, 20% of the time the bronchus moved in the
direction opposite to the PT.
Several studies have investigated whether changes in
AT lead to underdosage of tumor volume. In an attempt to
separate the dosimetric effects due to changes in lung
density from the resolution of AT and positional uncer-
tainty, Grams et al17 performed a simulation study of 20
patients wherein tumor and AT were replaced with lung
equivalent tissue to determine whether there was a sig-
niﬁcant dosimetric change that would require replanning.
The authors found that V95% of the planning target
volume changed only by 0.1%. However, when they
simulated positional changes by shifting the isocenter by
up to 5 mm in the LR, AP, and SI directions, they found
changes in the V95% of the planning target volume of up
to 4%. Thus, the positional changes that were caused by
changes in AT volume seem more important for target
dose coverage compared with changes in lung density.
Persoon et al18 used a 3-dimensional portal dose mea-
surement system to identify dose changes in 5 patients
with atelectasis. This study reported that in all cases in
which dosimetric changes were observed, change in
atelectasis also resulted in a shift of the tumor volume.
Moller et al12 conﬁrmed this observation in their study
of 24 patients with AT to determine the beneﬁt of adaptive
replanning. This study identiﬁed shifts >5 mm relative to
the spine and assessed whether these shifts would require
replanning. The study also assessed for replanning if there
was a signiﬁcant change in AT volume. Using cone beam
CT, the authors found that 70% of patients with AT would
require replanning to ensure good dosimetric coverage of
the target volume. However, in patients with PT shifts <5
mm, replanning was not helpful, which implies that the
geometrical shifts that were caused by AT were primarily
responsible for changes in dosimetric target coverage rather
than changes in the lung density that surrounds the target
volume. On the basis of these observations, we assume that
the large PT displacements that were observed in our study
would have likely caused tumor underdosage if they had
not been taken into account.
In a study on the impact of respiratory motion versus
anatomic changes over the course of radiation therapy,
Schmidt et al19 found that anatomic changes affected
dosimetry more than changes in respiratory motion and
that these changes cannot be reasonably accounted for by
increased margins. Adaptive therapy has been proposed to
reduce the target volume over the course of treatment to
ensure better target coverage and decrease normal tissue
toxicity.12,20-22 Given the anatomic changes that are
associated with AT, these patients likely need speciﬁcally
designed image guidance and adaptive protocols to
manage tumor coverage over the course of their treatment.
Conclusion
Patients with AT have signiﬁcantly greater PT
displacement than patients without AT. AT and PT vol-
ume changes during radiation treatment were associated
with tumor displacements that exceed standard setup
margins. The use of bronchi that are close to the PT to
assess the impact of AT change on PT shift without the
confounding issue of PT regression needs further study
before bronchi can be used as a surrogate for the PT.
Repeated 3-dimensional imaging is recommended in pa-
tients with AT to evaluate for PT displacements during
treatment and image guidance strategies such as a trafﬁc
light protocol11 should be considered to manage these
patients.
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